Ravulizumab in NMOSD with associated interstitial pneumonitis in a 59-year-old female patient: a case report. [PDF]
Front ImmunolNeundorf A, Dittrich R.
europepmc +1 more source
Optimizing Care in Patients with Paroxysmal Nocturnal Hemoglobinuria: Managing Suboptimal Response and Uncontrolled Disease. [PDF]
J Blood MedBienz M +3 more
europepmc +1 more source
Beyond Vaccination: Persistent Meningococcal Risk in Anti-C5-Treated aHUS-Case Report and Review of Literature. [PDF]
J Clin MedMatarese S +11 more
europepmc +1 more source
Assessing the Value Contribution of Vyvgart<sup>®</sup> (Efgartigimod Alfa) in the Treatment of Generalized Myasthenia Gravis with Acetylcholine Receptor Antibody in Spain Through Multi-criteria Decision Analysis. [PDF]
Adv TherCortés-Vicente E +9 more
europepmc +1 more source
C3 mutation-associated atypical hemolytic uremic syndrome with severe renal dysfunction and hypertensive emergency successfully treated with ravulizumab and sacubitril/valsartan: a case report. [PDF]
BMC NephrolYanagidani H +9 more
europepmc +1 more source
Oral Corticosteroid and Nonsteroidal Immunosuppressant Therapy Use in Patients with Myasthenia Gravis Receiving Ravulizumab, Eculizumab, or Efgartigimod in the USA. [PDF]
Neurol TherSaccà F +4 more
europepmc +1 more source
Comparing Efficacy and Safety of Various Monoclonal Antibodies in Myasthenia Gravis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. [PDF]
Brain BehavWaseem MH +5 more
europepmc +1 more source
Disease-modifying treatments in paroxysmal nocturnal hemoglobinuria: a systematic review of economic evaluations. [PDF]
Cost Eff Resour AllocMoradi S +4 more
europepmc +1 more source